Axl在急性髓系白血病中的表达及其临床意义

  • 摘要: 目的:通过检测Axl受体酪氨酸激酶在急性髓系白血病 (AML) 细胞中的表达水平,探讨Axl在AML多药耐药中的作用及其临床意义。方法:采用实时定量RT-PCR方法检测24例初治、11例复发/难治、12例完全缓解成人AML患者及11例对照者骨髓单个核细胞Axl mRNA的表达水平,并分析其在不同分组间的表达规律及与各临床特征、 缓解率之间的关系。结果:初治组及复发/难治组Axl mRNA表达水平均高于对照组 (Z分别为-2.791、 -2.310, P均<0.05);复发/难治组Axl mRNA表达水平明显高于初治组Axl mRNA表达水平 (Z=-2.239, P=0.025); 初治组Axl mRNA表达水平也显著高于完全缓解组 (Z=-1.956, P=0.040); 而对照组与完全缓解组之间比较差异无统计学意义 (Z=-0.895, P=0.325)。Axl的表达水平与初发未治AML患者性别、 年龄、 初诊白细胞数、 骨髓原始细胞百分数、 染色体核型及免疫表型无明显相关性 (P均>0.05); 初治组经2个疗程化疗后, 完全缓解组 (CR) 骨髓单个核细胞Axl mRNA表达量高于未完全缓解组 (PR+NR), 差异有统计学意义 (Z=-2.104, P=0.035)。结论:Axl mRNA高表达与AML患者的多药耐药及病情进展密切相关。

     

    Abstract: Expression and Clinical Significance of Axl in Acute Myeloid LeukemiaFanghui ZHOU, Juan FAN, Liping HAN, XinWANG, RuiWANG, Ying LICorrespondence to: Juan FAN, E-mail: fanjuan@medmail.com.cnDepartment of Hematology, Provincial Hospital Affiliated to Shandong University, Ji'nan 250021, ChinaThis work was supported by a grant from the: Science and Technology Development Program of Shandong Province (No.2007GG30002013)Abstract Objective: To explore the effects of receptor tyrosine kinase Axl on acute myeloid leukemia ( AML ) and to examine theexpression of Axl. Method: Real-time quantitative reverse-transcription polymerase chain reaction ( RQ-RT-PCR ) was used to detect AxlmRNA expression in bone marrow cells from 24 patients recently diagnosed with AML, 11 relapsed/refractory patients, 12 patients incomplete remission ( CR ) and 11 controls. The correlation of Axl expression with clinical remission rates was also examined. Results: ①The median mRNA expression of Axl in the 24 recently diagnosed patients and 11 relapsed/refractory patients was much higher than thatin the controls ( Z = -2.791, -2.310, P < 0.05 ). Furthermore, the Axl expression in relapsed/refractory patients was higher than in recentlydiagnosed patients (Z = -2.239, P = 0.025 ). The expression of Axl was much higher in recently diagnosed patients than in the CR group (Z = -1.956, P = 0.040). No statistical difference was found between the CR group and the control group ( Z = -0.895, P = 0.325). ②Therewas no correlation of Axl mRNA expression with gender, age, peripheral WBC ( white blood cell ) counts, bone marrow blast percentage,chromosome karyotypes and immunophenotype in recently diagnosed patients ( P > 0.05 ). ③After two courses of chemotherapy, the levelof Axl mRNA was much higher in the relapsed/refractory group than in the CR group ( Z = -3.465, P = 0.001 ). Conclusion: The level ofAxl mRNA expression is closely related to multidrug resistance and development of AML.Keywords Acute leukemia; Axl mRNA; Multidrug resistance; RQ-RT-PCR

     

/

返回文章
返回